An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.

Department of Urology, University of California at San Francisco Comprehensive Cancer Center, UCSF, San Francisco, CA 94143, USA.
Prostate cancer and prostatic diseases (Impact Factor: 2.83). 10/2008; 12(2):184-91. DOI: 10.1038/pcan.2008.45
Source: PubMed

ABSTRACT Prostate cancer is the second leading cause of cancer related deaths in US men, largely because of metastasis, which is ultimately fatal. A better understanding of metastasis biology will lead to improved prognostication and therapeutics. We previously reported 11q13.1 gain was independently predictive of recurrence after radical prostatectomy. Multiple endocrine neoplasia I (MEN1) maps to this region of copy number gain in aggressive prostate tumors and was shown to be the only gene at this locus at increased expression in prostate cancer. Here, we demonstrate an oncogenic role for MEN1 in prostate cancer using a variety of independent assays.

Download full-text


Available from: Colin C Collins, Jul 07, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In the context of multiple neuroendocrine tumor syndromes, reproductive abnormalities may occur via a number of different mechanisms, such as hyperprolactinemia, increased GH/IGF-1 levels, hypogonadotropic hypogonadism, hypercortisolism, hyperandrogenism, hyperthyroidism, gonadotropin hypersecretion, as well as, tumorigenesis or functional disturbances in gonads or other reproductive organs. Precocious puberty and/or male feminization is a feature of McCune-Albright syndrome (MAS), neurofibromatosis type 1 (NF1), Carney complex (CNC), and Peutz-Jeghers syndrome (PJS), while sperm maturation and ovulation defects have been described in MAS and CNC. Although tumorigenesis of reproductive organs due to a multiple neuroendocrine tumor syndrome is very rare, certain lesions are characteristic and very unusual in the general population. Awareness leading to their recognition is important especially when other endocrine abnormalities coexist, as occasionally they may even be the first manifestation of a syndrome. Lesions such as certain types of ovarian cysts (MAS, CNC), pseudogynecomastia due to neurofibromas of the nipple-areola area (NF1), breast disease (CNC and Cowden disease (CD)), cysts and 'hypernephroid' tumors of the epididymis or bilateral papillary cystadenomas (mesosalpinx cysts) and endometrioid cystadenomas of the broad ligament (von Hippel-Lindau disease), testicular Sertoli calcifying tumors (CNC, PJS) monolateral or bilateral macroochidism and microlithiasis (MAS) may offer diagnostic clues. In addition, multiple neuroendocrine tumor syndromes may be complicated by reproductive malignancies including ovarian cancer in CNC, breast and endometrial cancer in CD, breast malignancies in NF1, and malignant sex-cord stromal tumors in PJS.
    Endocrine Related Cancer 10/2009; 16(4):1125-38. DOI:10.1677/ERC-09-0057 · 4.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The ciliary body is a complex, highly specialized tissue that comprises several cell types. The ciliary muscle is situated at the base of the ciliary body and ligaments originating in the ciliary body attach to the lens. Contraction or relaxation of the muscle alters tension on the lens causing it to alter shape and thus shift focus. The surface of ciliary body is elaborated into a series of ridges named ciliary processes. Each ciliary process contains a complicated network of blood vessels that appear leaky to plasma constituents. The ciliary processes are covered by a specialized epithelium bilayer that comprises two distinct epithelial cell types, pigmented ciliary epithelium (PE) and nonpigmented ciliary epithelium (NPE). The ciliary epithelium bilayer constitutes a diffusion barrier between the blood and the aqueous humor in the interior of the eye. Barrier function depends on tight junctions between adjacent NPE cells. The ciliary body is responsible for the production of aqueous humor, a task that requires the polarized cellular distribution and coordinated function of Na, K-ATPase, Na/K/2Cl cotransporter, Na-H exchanger chloride channels and aquaporins in the NPE and PE. There is evidence suggesting an important role for gap junctions between the NPE and PE layers. The rate of aqueous humor secretion can be modified by ion transport inhibitors, by agents that modify gap junction permeability and by maneuvers that change blood flow in the ciliary processes.
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the past 3 years new insight into the etiopathogenesis of hereditary endocrine tumors has emerged from studies conducted on MENX, a rat multiple endocrine neoplasia (MEN) syndrome. MENX spontaneously developed in a rat colony and was discovered by serendipity when these animals underwent complete necropsy, as they were found to consistently develop multiple endocrine tumors with a spectrum similar to both MEN type 1 (MEN1) and MEN2 human syndromes. Genetic studies identified a germline mutation in the Cdkn1b gene, encoding the p27 cell cycle inhibitor, as the causative mutation for the MENX syndrome. Capitalizing on these findings, we and others identified heterozygous germline mutations in the human homologue, CDKN1B, in patients with multiple endocrine tumors. As a consequence of these observations a novel human MEN syndrome, named MEN4, was recognized which is caused by mutations in p27. Altogether these studies identified Cdkn1b/CDKN1B as a novel tumor susceptibility gene for multiple endocrine tumors in both rats and humans. In this chapter we present the MENX syndrome and its phenotype, and we compare it to the human MEN syndromes; we discuss the current state of knowledge regarding the genes associated to inherited MEN, with a particular focus on CDKN1B; we present recent clinical and basic findings about the MEN4 syndrome and the functional characterization of the CDKN1B mutations identified. These findings are placed in the broader context of how p27 dysregulation might affect neuroendocrine cell function and trigger tumorigenesis.
    Progress in brain research 01/2010; 182:295-320. DOI:10.1016/S0079-6123(10)82013-8 · 5.10 Impact Factor